Loading...
OTCM
TWSI
Market cap56kUSD
Jun 30, Last price  
0.00USD
Name

Inveritech Solutions Inc

Chart & Performance

D1W1MN
OTCM:TWSI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
21.17%
Revenues
0k
0005,23706,622,3621,075,902793,474921,2810003,776,0005,549,00000
Net income
-18k
L+187.34%
-695,236-350,992-2,155,049-4,079,353-19,133,234613,474-5,011,576-1,867,330867,547-2,384,990-288,546-2,248,000-12,628,000-8,874,000-6,400-18,390
CFO
-4m
L+74.00%
-403,633-120,705-1,242,765-616,550-1,140,249-2,797,650-2,152,224908,510-592,10541,336-372,000-2,573,000-4,477,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

TriStar Wellness Solutions Inc. specializes in the development, commercialization, and sale of various wound care products. The company's diverse portfolio extends to include skincare and other items specifically designed for pregnant and nursing women, marketed under the Beaute de Maman brand. They also provide solutions for bleeding and wound management, catering to a wide range of clients including surgical teams, general healthcare providers, consumers, and military markets. A key innovation from TriStar is its "Delivery Device with Invertible Diaphragm," a specialized medical applicator engineered for the safe and non-damaging internal administration of medicaments and other devices within the body. Furthermore, the company develops over-the-counter products aimed at itch suppression, and it is also involved in the development, manufacturing, and marketing of additional medical devices focused on wound care and infection control. Originally incorporated as BioPack Environmental Solutions, Inc., the company officially changed its name to TriStar Wellness Solutions, Inc. in January 2013. Based in Portland, Oregon, TriStar Wellness Solutions, Inc. ultimately faced financial difficulties, leading to a voluntary petition for liquidation under Chapter 7, filed on January 15, 2016, in the U.S. Bankruptcy Court for the District of Oregon.
IPO date
Jun 25, 2001
Employees
35
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFY
2024‑122023‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT